These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17049192)

  • 41. Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium.
    Dhillon J; Lowrie DB; Mitchison DA
    BMC Infect Dis; 2004 Nov; 4():51. PubMed ID: 15548322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies.
    Viswanathan V; Pharande R; Bannalikar A; Gupta P; Gupta U; Mukne A
    Drug Dev Ind Pharm; 2019 Jan; 45(1):11-20. PubMed ID: 30122088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.
    Zhang Y; Wade MM; Scorpio A; Zhang H; Sun Z
    J Antimicrob Chemother; 2003 Nov; 52(5):790-5. PubMed ID: 14563891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effectiveness of liposomal antibacterial drugs in the inhalation therapy of experimental tuberculosis].
    Kurunov IuN; Ursov IG; Krasnov VA; Petrenko TI; Iakovchenko NN; Svistelńik AV; Filimonov PA
    Probl Tuberk; 1995; (1):38-40. PubMed ID: 7761379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
    Garca-Doval I
    J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
    [No Abstract]   [Full Text] [Related]  

  • 46. The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis.
    Martins M; Viveiros M; Kristiansen JE; Molnar J; Amaral L
    In Vivo; 2007; 21(5):771-5. PubMed ID: 18019410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
    Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
    Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
    PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
    Martin A; Cubillos-Ruiz A; Von Groll A; Del Portillo P; Portaels F; Palomino JC
    J Antimicrob Chemother; 2008 Jan; 61(1):123-7. PubMed ID: 17981833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Symposium on drug resistant tuberculosis. Reserve drug combinations.
    Mitchison DA
    J Ir Med Assoc; 1970 Mar; 63(393):86-91. PubMed ID: 4984341
    [No Abstract]   [Full Text] [Related]  

  • 52. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
    Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
    Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
    Meers P; Neville M; Malinin V; Scotto AW; Sardaryan G; Kurumunda R; Mackinson C; James G; Fisher S; Perkins WR
    J Antimicrob Chemother; 2008 Apr; 61(4):859-68. PubMed ID: 18305202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats.
    De Rosa HJ; Baldan HM; Brunetti IL; Ximenes VF; Machado RG
    Biopharm Drug Dispos; 2007 Sep; 28(6):291-6. PubMed ID: 17571294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary delivery of pyrazinamide-loaded large porous particles.
    Pham DD; Grégoire N; Couet W; Gueutin C; Fattal E; Tsapis N
    Eur J Pharm Biopharm; 2015 Aug; 94():241-50. PubMed ID: 26036447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood levels of pyrazinamide in children at doses administered under the Revised National Tuberculosis Control Program.
    Roy V; Sahni P; Gupta P; Sethi GR; Khanna A
    Indian Pediatr; 2012 Sep; 49(9):721-5. PubMed ID: 22317983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pyrazinamide use as a method of estimating under-reporting of tuberculosis.
    van Loenhout-Rooyackers JH; Leufkens HG; Hekster YA; Kalisvaart NA
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1156-60. PubMed ID: 11769775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83.
    Yu DH; Hu XD; Cai H
    Gene Ther; 2008 May; 15(9):652-9. PubMed ID: 18288210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spray Dried Aerosol Particles of Pyrazinoic Acid Salts for Tuberculosis Therapy. [Corrected].
    Durham PG; Zhang Y; German N; Mortensen N; Dhillon J; Mitchison DA; Fourie PB; Hickey AJ
    Mol Pharm; 2015 Aug; 12(8):2574-81. PubMed ID: 26098136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
    Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
    J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.